PRESS RELEASES
BIOPETROL INDUSTRIES concludes contract to build its third plant
NB: Please note the disclaimer at the end of this press release
May 17, 2006. Biodiesel producer BIOPETROL INDUSTRIES AG has now put all the foundations in place for its third production facility. It will be erected in Rotterdam and will be constructed by renowned biodiesel plant builder, Lurgi AG. BIOPETROL ROTTERDAM B.V., Netherlands, signed the corresponding contract with Lurgi yesterday evening.
In Rotterdam a production plant is planned with a capacity of 400,000 tons of biodiesel, 60,000 tons of pharmaceutical glycerine and 60,000 tons re-esterification of fatty acids. Start up for the plant is scheduled for Q3 2007. The investment volume for the two latest BIOPETROL INDUSTRIES plants in Rostock and Rotterdam will be around EUR 90 million in total after deducting subsidies.
Christoph Dicks, CEO of BIOPETROL INDUSTRIES AG, commented: "By signing the contract we have realized our growth plans faster than originally planned. By year-end 2007 we intend the BIOPETROL Group to comprise three production plants delivering a total annual capacity of 750,000 tons of biodiesel and 90,000 tons of pharmaceutical glycerine."
The details of the production capacities and investments initiated:
- At present, at its Schwarzheide facility in Brandenburg, BIOPETROL INDUSTRIES AG rolls out about 150,000 tons of biodiesel and 30,000 tons pharmaceutical glycerine a year.
- The foundation stone for the second plant in Rostock was laid in January. It should go into operation in the last quarter of this year and turn out 200,000 tons of biodiesel, as well as 20,000 tons or crude glycerine a year.
- As of 2008, the third plant in Rotterdam will produce around 400,000 tons of biodiesel and 60,000 tons of pharmaceutical glycerine. In terms of technical construction, the facilities in Rotterdam will be similar to those in Rostock.
The Company
BIOPETROL INDUSTRIES AG, based in Zug, Switzerland, produces and distributes premium quality biodiesel and pharmaceutical grade glycerine through its subsidiaries. Its clients include the mineral oil industry and resellers, large fleet operators and public transport companies. Moreover, pharmaceutical glycerine is supplied to the pharmaceuticals and cosmetics industry.
Disclaimer
This communication is neither an offer to sell nor a request to make an offer to buy or subscribe to securities. This communication and the information it contains are not intended for direct or indirect forwarding to or inside the United States of America, Canada, Australia or Japan.
[ Home | Sitemap | Credits | Deutsch | Nederlands ]
Print
Recommend